SNWV Relative Valuation
SNWV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SNWV is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-20.92
P/B
Median3y
-16.13
Median5y
-16.13
0.74
FCF Yield
Median3y
0.54
Median5y
0.54
Competitors Valuation Multiple
The average P/S ratio for SNWV's competitors is 2.78, providing a benchmark for relative valuation. Sanuwave Health, Inc. Corp (SNWV) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
People Also Watch
AVO
Mission Produce Inc
9.740
USD
-2.79%
KRUS
Kura Sushi USA Inc
50.910
USD
-6.71%
NESR
National Energy Services Reunited Corp
6.040
USD
-2.89%
UTL
Unitil Corp
56.190
USD
+0.39%
UAN
CVR Partners LP
67.840
USD
-2.56%
BFS
Saul Centers Inc
32.320
USD
-3.58%
MRNO
Murano Global Investments Plc
9.500
USD
+9.20%
GRNT
Granite Ridge Resources Inc
4.750
USD
-8.48%
DMRC
Digimarc Corp
11.630
USD
-8.06%
HTLD
Heartland Express Inc
8.630
USD
-1.37%
FAQ
Is Sanuwave Health, Inc. (SNWV) currently overvalued or undervalued?
Sanuwave Health, Inc. (SNWV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Sanuwave Health, Inc. (SNWV) is between to according to relative valuation methord.
What is Sanuwave Health, Inc. (SNWV) fair value?
How does SNWV's valuation metrics compare to the industry average?
What is the current P/B ratio for Sanuwave Health, Inc. (SNWV) as of Apr 11 2025?
What is the current FCF Yield for Sanuwave Health, Inc. (SNWV) as of Apr 11 2025?
What is the current Forward P/E ratio for Sanuwave Health, Inc. (SNWV) as of Apr 11 2025?